330 related articles for article (PubMed ID: 16358954)
1. Peroxisome proliferator-activated receptor gamma ligand prevents the development of chronic pancreatitis through modulating NF-kappaB-dependent proinflammatory cytokine production and pancreatic stellate cell activation.
Hisada S; Shimizu K; Shiratori K; Kobayashi M
Rocz Akad Med Bialymst; 2005; 50():142-7. PubMed ID: 16358954
[TBL] [Abstract][Full Text] [Related]
2. Thiazolidinedione derivatives as novel therapeutic agents to prevent the development of chronic pancreatitis.
Shimizu K; Shiratori K; Hayashi N; Kobayashi M; Fujiwara T; Horikoshi H
Pancreas; 2002 Mar; 24(2):184-90. PubMed ID: 11854624
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice.
van Westerloo DJ; Florquin S; de Boer AM; Daalhuisen J; de Vos AF; Bruno MJ; van der Poll T
Am J Pathol; 2005 Mar; 166(3):721-8. PubMed ID: 15743784
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor γ agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor κB and activator protein 1.
Gao M; Hu Z; Zheng Y; Zeng Y; Shen X; Zhong D; He F
Shock; 2011 Sep; 36(3):228-34. PubMed ID: 21617575
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.
Doi S; Masaki T; Arakawa T; Takahashi S; Kawai T; Nakashima A; Naito T; Kohno N; Yorioka N
Transplantation; 2007 Jul; 84(2):207-13. PubMed ID: 17667812
[TBL] [Abstract][Full Text] [Related]
7. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma.
Alleva DG; Johnson EB; Lio FM; Boehme SA; Conlon PJ; Crowe PD
J Leukoc Biol; 2002 Apr; 71(4):677-85. PubMed ID: 11927655
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages.
Ringseis R; Schulz N; Saal D; Eder K
J Nutr Biochem; 2008 Sep; 19(9):594-603. PubMed ID: 18155510
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone inhibits the progression of chronic pancreatitis and the profibrogenic activity of pancreatic stellate cells via a PPARgamma-independent mechanism.
Shimizu K; Shiratori K; Kobayashi M; Kawamata H
Pancreas; 2004 Jul; 29(1):67-74. PubMed ID: 15211114
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
11. Peptide YY attenuates transcription factor activity in tumor necrosis factor-alpha-induced pancreatitis.
Vona-Davis L; Yu A; Magabo K; Evans T; Jackson B; Riggs D; McFadden D
J Am Coll Surg; 2004 Jul; 199(1):87-95. PubMed ID: 15217635
[TBL] [Abstract][Full Text] [Related]
12. Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver.
Romics L; Kodys K; Dolganiuc A; Graham L; Velayudham A; Mandrekar P; Szabo G
Hepatology; 2004 Aug; 40(2):376-85. PubMed ID: 15368442
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
[TBL] [Abstract][Full Text] [Related]
14. A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosis.
Reding T; Bimmler D; Perren A; Sun LK; Fortunato F; Storni F; Graf R
Gut; 2006 Aug; 55(8):1165-73. PubMed ID: 16322109
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 1 receptor-dependent nuclear factor-kappaB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis.
Chan YC; Leung PS
J Pharmacol Exp Ther; 2007 Oct; 323(1):10-8. PubMed ID: 17616560
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells.
Sung CK; She H; Xiong S; Tsukamoto H
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G722-9. PubMed ID: 14656714
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats.
Kuno A; Yamada T; Masuda K; Ogawa K; Sogawa M; Nakamura S; Nakazawa T; Ohara H; Nomura T; Joh T; Shirai T; Itoh M
Gastroenterology; 2003 Apr; 124(4):1010-9. PubMed ID: 12671898
[TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth.
Xu J; Fu Y; Chen A
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G20-30. PubMed ID: 12660143
[TBL] [Abstract][Full Text] [Related]
20. [The effect of activated nuclear factor-kappaB in pathogenesis of acute pancreatitis].
Su JR; Zhao ZC; Chen WL; Wang X
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1497-500. PubMed ID: 14521729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
